TickerKhojChemicals · Chemicals: Specialty · NSE: TRUALT · data 2026-11-02
Trualt Bioenergy Limited
In plain words
Price: 32.4% below its 52-week high of ₹542.
Delivery: 53.6% of traded shares were kept for delivery over the last 10 sessions, against 55.4% over the last 60.
Latest results: a net profit of ₹35 cr for the quarter ended Sept 2026.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹2,747 cr |
| Net profit (last 12 months) | ₹221 cr |
| Sales growth, 3 years (yearly) | 29.9% |
| Profit growth, 3 years (yearly) | 39.3% |
At a glance
Promoters 71.4%, pledged 39.2%, institutions 9.7%.
P/E 14.2, P/B 1.9, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 8.4%, ROCE 6.3%, operating margin 14.3%: how much profit it earns on the money it uses.
Debt/equity 1.09, Profit growth 39.3% and sales growth 29.9% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Profit grew 39.3% a year over 3 years.
- Promoters have pledged 39.2% of their shares.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q2 FY27)
TRUALT Q2 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹811.1 crore, up 606.2% YoY and up 29.4% QoQ.
Net profit was ₹34.68 crore, a turn to profit from a loss a year ago and down 39.3% QoQ.
Operating margin was 12.5% (4% a year ago).
EPS was ₹4.04, positive against a negative EPS a year ago and down 39.4% QoQ.
TRUALT के Q2 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹811.1 करोड़; पिछले साल की तुलना में 606.2% की बढ़त, पिछली तिमाही की तुलना में 29.4% की बढ़त।
शुद्ध मुनाफ़ा: ₹34.68 करोड़; एक साल पहले के घाटे से मुनाफ़े में आया, पिछली तिमाही की तुलना में 39.3% की गिरावट।
ऑपरेटिंग मार्जिन: 12.5% (एक साल पहले 4%)।
EPS: ₹4.04; एक साल पहले के ऋणात्मक EPS से धनात्मक हुआ, पिछली तिमाही की तुलना में 39.4% की गिरावट।
TRUALTના Q2 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹811.1 કરોડ; ગયા વર્ષની સરખામણીએ 606.2% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 29.4% વધારો.
ચોખ્ખો નફો: ₹34.68 કરોડ; એક વર્ષ પહેલાંની ખોટમાંથી નફામાં આવી, ગયા ક્વાર્ટરની સરખામણીએ 39.3% ઘટાડો.
ઓપરેટિંગ માર્જિન: 12.5% (એક વર્ષ પહેલાં 4%).
EPS: ₹4.04; એક વર્ષ પહેલાંના નકારાત્મક EPSથી હકારાત્મક થઈ, ગયા ક્વાર્ટરની સરખામણીએ 39.4% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
22/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Delivery 50.8% over the last 20 sessions vs 57.7% in the 40 before (0.88x); shares delivered per day 0.77x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 17/20: Net +₹19.88 cr bought in bulk/block deals over 90 days (1.89x a usual day's traded value); 1 net buying day, 0 net selling days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results ● Deal
- 23 Oct 26Results Q2 FY27 results: turned to profit vs a year ago -6.3% next session
- 25 Sept 26Results Q4 FY26 results: net profit ₹59.9 cr +6.8% next session
- 23 Sept 26Deal Bulk deal: SIDDHISURI FINVEST PRIVATE LIMITED bought ₹19.88 cr +3.5% next session
- 28 Jul 26Results Q1 FY27 results: profit +1108.2% YoY +2.1% next session
- 24 Jul 26Results Results board meeting -2.5% next session
- 22 May 26Results Results board meeting +1.3% next session
- 3 Feb 26Results Q3 FY26 results: net profit ₹69.3 cr -0.1% next session
- 12 Nov 25Results Q2 FY26 results: net profit −₹37.9 cr +2.9% next session
- 21 Oct 25Results Q1 FY26 results: net profit ₹4.7 cr +0.2% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Sept 2026 | ₹811 cr | ₹35 cr | — | 12.5% | 4.04 |
| Jun 2026 | ₹627 cr | ₹57 cr | +1108.2% | 21.2% | 6.67 |
| Mar 2026 | ₹596 cr | ₹60 cr | — | 19.9% | 6.99 |
| Dec 2025 | ₹713 cr | ₹69 cr | — | 18.8% | 8.07 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 71.38% | 70.55% | 70.55% | 70.55% |
| Foreign institutions (FII) | 0.63% | 0.58% | 0.66% | 0.93% |
| Domestic institutions (DII) | 9.09% | 8.36% | 9.40% | 7.27% |
| Mutual funds | 7.11% | 6.76% | 6.70% | 4.35% |
| Retail investors | 6.31% | 6.31% | 5.59% | 6.13% |
| Number of shareholders | 60,248 | 62,478 | 73,790 | 80,013 |
Common questions
What was Trualt Bioenergy Limited's latest quarterly profit?
Trualt Bioenergy Limited reported a net profit of ₹35 cr for the quarter ended Sept 2026, on revenue of ₹811 cr.
How much do promoters hold in Trualt Bioenergy Limited?
Promoters held 71.38% of Trualt Bioenergy Limited at the end of Sept 2026, with 39.20% of promoter shares pledged.
Is Trualt Bioenergy Limited debt-free?
Its latest reported debt-to-equity ratio is 1.09, meaning borrowings are larger than shareholders' equity.
What is Trualt Bioenergy Limited's P/E ratio?
About 14.2, based on the last 12 months' earnings and a price of ₹366.5 (data 2026-11-02).
What is the 52-week high and low of Trualt Bioenergy Limited?
The 52-week high is ₹542 and the 52-week low is ₹310.2.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Trualt Bioenergy Limited | ₹366.5 | ₹3,090 cr | 14.2 | 1.9 | 8.4% | 6.3% | 1.09 | -19.6% |
| Vishnu Chemicals Limited | ₹510.05 | ₹3,648 cr | 22.9 | — | 14.3% | 16.2% | 0.49 | +4.3% |
| Grauer & Weil India Ltd. | ₹80.07 | ₹3,637 cr | 22.7 | — | 16.2% | 16.4% | 0.01 | +33.3% |
| Kiri Industries Limited | ₹543.8 | ₹3,517 cr | 0.6 | — | 115% | -2.6% | 0.01 | -1.0% |
| Styrenix Performance Materials Ltd | ₹1,745.7 | ₹3,075 cr | 12.2 | 2.1 | 14.4% | 13.2% | 0.4 | -27.3% |
| Polyplex Corporation Limited | ₹912.4 | ₹2,811 cr | 18.4 | — | 1.1% | 1.9% | 0.22 | -5.1% |
Compare TRUALT with VISHNU in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open TRUALT in TickerKhoj →